Skip to main content
SpringerLink
Log in
Book cover

Recent Developments in Alcoholism pp 25–38Cite as

Biomarkers as Aids to Identification of Relapse in Alcoholic Patients

  • Chapter

Part of the book series: Recent Developments in Alcoholism ((RDIA,volume 16))

Abstract

Since return to drinking is common in patients recovering from alcoholism, recognition of relapse should be an important component of treatment. Recurrent assessment with biochemical measures can provide clinicians with useful information on the drinking status of their patients. This chapter addresses issues surrounding the importance of early detection of relapse, describes biochemical markers that may assist in this, reviews relevant scientific investigations, and offers recommendations to researchers and clinicians.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD   169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD   169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Miller, W.R., Walter, S.T., & Bennett, M.E. How effective is alcoholism treatment in the United States. Journal of Studies on Alcohol 62: 211–220, 2001.

    PubMed  Google Scholar 

  2. Fuller, R.K. & Allen, J.P. Patient-to-treatment matching. In Zernig, G., Saria, A., Kurz, M.D., & O’Malley, S.S. (eds.), Handbook of Alcoholism. New York, CRC Press, 2000, pp. 363–368.

    Google Scholar 

  3. Connors, G.J., Maisto, S.A., & Donovan, D.M. Conceptualizations of relapse: A summary of psychological and biological models. Addiction, 91(suppl): 5–14, 1996.

    Google Scholar 

  4. Donovan, D.M. Continuing care. In Miller, W.R. & Heather, N. (eds.), Treating Addictive Behaviors. Plenum Press, 1996, pp. 317–336.

    Google Scholar 

  5. Babor, T.F., Steinberg, K., Anton, R., & Del Boca, F. Talk is cheap: Measuring drinking outcomes in clinical trials. Journal of Studies on Alcohol, 61: 55–63, 2000.

    PubMed  Google Scholar 

  6. Mundle, G., Ackermann, K., & Mann, K. Biological markers as indicators for relapse in alcohol-dependent patients. Addiction Biology, 4: 209–214, 1999.

    Google Scholar 

  7. Mundle, G., Ackermann, K., Gunthner, A., Munkes, J., & Mann, K. Treatment outcome in alcoholism—A comparison of self-report and the biological markers carbohydrate-deficient transferring and γ-glutamyl transferase. European Addiction Research 5: 9–96, 1999.

    Article  Google Scholar 

  8. Borg, S., Helander, A., Carlsson., Voltaire, A., & Brandt Hogstrom, A.M. Detection of relapses in alcohol-dependent patients using carbohydrate-deficient transferrin: Improvement with individualized reference levels during long-term monitoring. Alcoholism Clinical and Experimental Research 19(4): 961–963, 1995.

    Google Scholar 

  9. Keso, L. & Salaspuro, M. Comparative value of self-report and blood tests in assessing outcome amongst alcoholics. British Journal of Addictions 85: 200–215, 1990.

    Google Scholar 

  10. Mitchell, C., Simpson, D., & Chick, J. Carbohydrate deficient transferrin in detecting relapse in alcohol dependence. Drug and Alcohol Dependence 48: 97–103, 1997.

    Article  PubMed  Google Scholar 

  11. Rosman, A.S., Basu, P., Galvin, K., & Lieber, C.S. Utility of carbohydrate-deficient transferrin as a marker of relapse in alcoholic patients. Alcoholism Clinical and Experimental Research 19(3): 611–616, 1995.

    Google Scholar 

  12. Anton, R.F., Litten, R.Z., & Allen, J.P. Biological assessment of alcohol consumption. In Allen, J.P. & Columbus M. (eds.), Assessing Alcohol Problems. Bethesda, MD: USDHHS, 1995,. pp. 31–40.

    Google Scholar 

  13. Allen, J.P., Sillanaukee, P., & Anton, R. Contribution of carbohydrate deficient transferrin to gamma glutamyl transpeptidase in evaluating progress of patients in treatment for alcoholism. Alcoholism Clinical and Experimental Research 23(1): 115–120, 199.

    Google Scholar 

  14. Allen, J.P., Litten, R.Z., Sillanaukee, P. & Strid, N. The role of biomarkers in alcohol medication trials. Alcoholism Clinical and Experimental Research (in press).

    Google Scholar 

  15. Zimmermann, H.J. & West, M. Serum enzyme levels in the diagnosis of hepatic disease. American Journal of Gastroenterology 40: 387–404, 1963.

    Google Scholar 

  16. Reichling, J.J. & Kaplan, M.M. Clinical use of serum enzymes in liver disease. Digestive Disorders Science 33: 1601–1614, 1988.

    Google Scholar 

  17. Konttinen, A., Hartel, G., & Louhija, A. Multiple serum enzyme analysis in chronic alcoholics. Acta Medica Scandanavica 188: 257–264, 1970.

    Google Scholar 

  18. Skude, G. & Wadstein, J. Amylase, hepatic enzymes and bilirubin in serum of alcoholics. Acta Medica Scandanavica 201: 53–58, 1977.

    Google Scholar 

  19. Matloff, D.S., Selinger, M.J., & Kaplan, M.M. Hepatic transaminase activity in alcoholic liver disease. Gastroenterology 78: 1389–1392, 1980.

    PubMed  Google Scholar 

  20. Buffet, C., Chaput, J., Albuisson, F., et al. La macrocytose dans ľhepatite alcoolique chronique histologiquement prouvee. Archives Francaises Medicales Applications Digest 64: 309–315, 1975.

    Google Scholar 

  21. Whitehead, T.P., Clarke, C.A., Bayliss, R.I., & Whitfield, A.G. Mean red cell volume as a marker of alcohol intake. Journal of the Royal Society of Medicine 78: 880–881, 1985.

    PubMed  Google Scholar 

  22. Stibler, H. & Borg, S. The value of carbohydrate-deficient transferrin as a marker of high alcohol consumption. In Kuriyama, K., Takaya, A., & Ishii, H. (eds.), Biochemical and Social Aspects of Alcohol and Alcoholism. Amsterdam. Elsevier Science, 1988, pp. 503–506.

    Google Scholar 

  23. Sillanaukee, P., Strid, N., Allen, J.P., & Litten, R.Z. Possible reasons why heavy drinking increases carbohydrate-deficient transferrin. Alcoholism Clinical and Experimental Research 25(1): 34–40, 2001.

    Google Scholar 

  24. Stibler, H. Carbohydrate-deficient transferrin in serum: A new marker of potentially harmful alcohol consumption reviewed. Clinical Chemistry 37: 2029–2037, 1991.

    PubMed  Google Scholar 

  25. Bean, P. & Peter, J.B. Allelic D variants of transferrin in evaluation of alcohol abuse: Differential diagnosis by isoelectric focusing-immunoblotting-laser densitometry. Clinical Chemistry 40: 2078–2083, 1994.

    PubMed  Google Scholar 

  26. Niemela, O., Sorvajarvi, K., Blake, J.E., et al. Carbohydrate-deficient transferrin as a marker of alcohol abuse: Relationship to alcohol consumption, severity of liver disease, and fibrogenesis. Alcoholism Clinical and Experimental Research 19: 1203–1208. 1995.

    Google Scholar 

  27. Arndt, T., Hackler, R., Miller, T., Kleine, T.O., & Gressner, A.M. Increased serum concentration of carbohydrate deficient transferrin in patients with combined pancreas and kidney transplantation. Clinical Chemistry 43: 344–351, 1997.

    PubMed  Google Scholar 

  28. Litten, R.Z., Allen, J.P., & Fertig, J.B. γ-glutamyltranspeptidase and carbohydrate deficient transferrin: Alternative measures of excessive alcohol consumption. Alcoholism Clinical and Experimental Research 9(6): 1541–1546, 1995.

    Google Scholar 

  29. Voltaire, A., Beck, O., & Borg, S. Urinary 5-hydroxytryptophol: A possible marker of recent alcohol consumption. Alcoholism Clinical and Experimental Research, 16: 281–285, 1992.

    Google Scholar 

  30. Feldman, J.M. & Lee, E.M. Serotonin content of foods: Effect on urinary excretion of 5-hydroxy-indoleacetic acid. American Journal of Clinical Nutrition 42: 639–643, 1985.

    PubMed  Google Scholar 

  31. Borg, S., Beck, O., Helander, A., Voltaire, A., & Stibler, H. Carbohydrate-deficient transferrin and 5-hydroxytryptophol: Two new markers of high alcohol consumption. In Litten, R.A. & Allen, J.P. (eds.), Measuring Alcohol Consumption. Totowa, NJ, Humana Press, pp. 149–155.

    Google Scholar 

  32. Helander, A. Monitoring relapse drinking during disulfiram therapy by assay of urinary 5-hydroxytryptophol. Alcoholism Clinical and Experimental Research 22: 111–114, 1998.

    Google Scholar 

  33. Shaw, S., Worner, T.M., Borysow, M.F., Schmitz, R.E., & Lieber, C.S. Detection of alcoholism relapse: Comparative diagnostic value of MCV, GGTP, and AANB. Alcoholism Clinical and Experimental Research 3: 297–301, 1978.

    Google Scholar 

  34. Irwin, M, Baird, S., Smith, T.L., & Schuckit, M. Use of laboratory tests to monitor heavy drinking by alcoholic men discharged from a treatment program. American Journal of Psychiatry 145: 5, 1988.

    Google Scholar 

  35. Sobell, L.C. & Sobell, M.B. Alcohol consumption measures. In Allen, J.P. & Columbus, M. (eds.), Assessing Alcohol Problems. Bethesda, MD USDHHS, 1995, pp. 55–74.

    Google Scholar 

  36. Berlakovich, G.A., Windhager, T., Freundorfer, E., Lesch, O.M., Steininger, R. & Mulbacher, F. Carbohydrate deficient transferrin for detection of alcohol relapse after orthotopic liver transplantation for alcoholic cirrhosis. Transplantation 67(9): 1232–1235, 1999.

    Google Scholar 

  37. Limin, S., Jarvis, D.R., Chick, J., & Simpson, C.D. Limitations of CDT and GGT in detecting relapses in patients attending an alcohol problems clinic. Scottish Medical Journal 44: 140–142, 1999.

    PubMed  Google Scholar 

  38. Kverme, A.T. & Buchmann, M. Carbohydrate deficient transferrin (CDT) and gamma-glutamyltransferase (GGT) in diagnosis and monitoring of abstinence among alcohol abusers. Hepatology 26 (4 Part 2): 544A, 1997.

    Google Scholar 

  39. Schmidt, L.G., Schmidt, K., Dufeu, P., Ohse, A., Rommelspacher, H., & Muller, C. Superiority of carbohydrate-deficient transferrin to gamma-glutamyltransferase in detecting relapse in alcoholism. American Journal of Psychiatry 154(1): 75–80, 1997.

    PubMed  Google Scholar 

  40. Myrick, H., Henderson, S., & Anton, R.F. Utility of a new assay for carbohydrate-deficient transferring to monitor abstinence during a treatment outcome study. Alcoholism Clinical and Experimental Research, in press.

    Google Scholar 

  41. Anton, R.F., Lieber, C., & Tabakoff, B. (for the CDTect Study Group). Carbohydrate deficient transferrin (CDT) and gamma-glutamyltransferase for the detection and monitoring of alcoholics. Manuscript submitted for publication.

    Google Scholar 

  42. Behrens, U.J., Worner, T.M., & Lieber, C.S. Changes in carbohydrate-deficient transferrin levels after alcohol withdrawal. Alcoholism Clinical and Experimental Research 12 (4): 539–544, 1988.

    Google Scholar 

  43. Monteiro, M.G. & Masur, J. Monitoring alcoholism treatment: The appropriateness of choice betweeen γGT or MCV evaluation after a short time of abstinence. Alcohol 3: 223–226, 1986.

    Article  PubMed  Google Scholar 

  44. Sillanaukee, P., Massot, N., Jousilahti, P., Vartiainen, E., Poikolainen, K., Olsson, U., & Alho, H. Enhanced clinical utility of γ-CDT in a general population. Alcoholism Clinical and Experimental Research 24(8): 1202–1206, 2000.

    Google Scholar 

  45. Burke, V., Puddey, I.B., Rakic, V., Swanson, N.R., Dimmitt, S.B., Beilin, S.B., Ching, S., & Beilby, J.P. Carbohydrate-deficient transferrin as a marker of change in alcohol intake in men drinking 20 to 60 g of alcohol per day. Alcoholism Clinical and Experimental Research 22: 1973–1980, 1998.

    Google Scholar 

  46. Anton, R.F. Moak, D.H., & Latham, P. Carbohydrate deficient transferrin as an indicator of drinking status during a treatment outcome study. Alcoholism Clinical and Experimental Research 2(5): 842–846, 1996.

    Google Scholar 

  47. Swift, R.M., Martin, C.S., Swette, L., LaConti, A., & Kackley, N. Studies on wearable, electronic, transdermal alcohol sensor. Alcohol Clin Exp Res 16: 721–725.

    Google Scholar 

  48. Collins, M.A. Acetaldehyde and its condensation products as markers in alcoholism. Recent Developments in Alcohol 6: 387–403, 1988.

    Google Scholar 

  49. Goldberg, D.M. & Kapur, B.M. Enzymes and circulating proteins as markers of alcohol abuse. Clinica Chimica Acta. 226: 191–209, 1994.

    Article  Google Scholar 

  50. Niemela, O. Aldehyde-protein adducts in the liver as a result of ethanol-induced oxidative stress. Frontiers In Bioscience 4: 506–513, 1999.

    Google Scholar 

  51. Tsukamoto, S., Kanegae, T., Isobe, E., Hirose, M., & Nagoya, T. Determinations of free and bound ethanol, acetaldehyde, and acetate in human blood and urine by headspace gas chromatography. Nihon Arukoru Yakubutsu Igakkai Zasshi 33: 200–209, 1988.

    Google Scholar 

  52. Peterson, C.M. & Scott, B.K. Studies of whole blood associated acetaldehyde as a marker for alcohol intake in mice. Alcoholism Clinical and Experimental Research 13: 845–848, 1989: Anton, R.F., Moak, D.H., & Latham, P. Carbohydrate-deficient transferrin as an indicator of drinking status during a treatment outcome study. Alcoholism Clinical and Experimental Research 20(5): 841–846, 1996.

    Google Scholar 

  53. Pantoja, A., Scott, B.K., & Peterson, CM. Studies of urine-associated acetaldehyde as a marker for alcohol intake in mice. Alcohol 8: 439–441, 1991.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Institute on Alcohol Abuse and Alcoholism, Bethesda, Maryland, 20892

    John P. Allen

  2. Center for Drug and Alcohol Programs, Alcohol Research Center, Medical University of South Carolina, Charleston, South Carolina

    Raymond Anton

Authors
  1. John P. Allen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Raymond Anton
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. New York University School of Medicine, New York, New York

    Marc Galanter

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic Publishers

About this chapter

Cite this chapter

Allen, J.P., Anton, R. (2002). Biomarkers as Aids to Identification of Relapse in Alcoholic Patients. In: Galanter, M., et al. Recent Developments in Alcoholism. Recent Developments in Alcoholism, vol 16. Springer, Boston, MA. https://doi.org/10.1007/0-306-47939-7_4

Download citation

  • DOI: https://doi.org/10.1007/0-306-47939-7_4

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-306-47258-9

  • Online ISBN: 978-0-306-47939-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation